RAP Chart, page-182

While I want the company to succeed I think it is very naive to say FDA approval will be 120 days or less when the de novo process has an average of 360 days. The company itself has been letting timelines slip constantly as of late, let's just try be more realisitic.

Until contracts are entered into/signed we have no idea what revenues will be (I personally think they will be unprecedented). We just have to keep in mind ourselves, and this company, are exploring uncharted territory. There is nothing else like this out there.

The SP will always be a bit wobbly until revenue is actually determined. I still believe strongly in the product that is being offered, it truly is a unique opportunity.